Key result
TWEAK drives cardiomyocyte proliferation through FN14 signaling in neonatal models.
Why the study?
Proliferation of mammalian cardiomyocytes stops early after birth, limiting heart regeneration, and novel factors inducing cardiomyocyte proliferation need identification.
Answers are grounded in this paper and cite their sources.
TWEAK is a positive regulator of cardiomyocyte proliferation, highlighting a potential therapeutic pathway for cardiac regeneration.
AIMS: Proliferation of mammalian cardiomyocytes stops during the first weeks after birth, preventing the heart from regenerating after injury. Recently, several studies have indicated that induction of cardiomyocyte proliferation can be utilized to regenerate the mammalian heart. Thus, it is important to identify novel factors that can induce proliferation of cardiomyocytes. Here, we determine the effect of TNF-related weak inducer of apoptosis (TWEAK) on cardiomyocytes, a cytokine known to regulate proliferation in several other cell types. METHODS AND RESULTS: Stimulation of neonatal rat cardiomyocytes with TWEAK resulted in increased DNA synthesis, increased expression of the proliferative markers Cyclin D2 and Ki67, and downregulation of the cell cycle inhibitor p27KIP1. Importantly, TWEAK stimulation resulted also in mitosis (H3P), cytokinesis (Aurora B), and increased cardiomyocyte numbers. Loss of function experiments revealed that re-induction of proliferation was dependent on tumour necrosis factor receptor superfamily member 12A (FN14) signalling. Downstream signalling was mediated through activation of extracellular signal-regulated kinases and phosphatidylinositol 3-kinase as well as inhibition of glycogen synthase kinase-3beta. In contrast to neonatal cardiomyocytes, TWEAK had no effect on adult rat cardiomyocytes due to developmental downregulation of its receptor FN14. However, adenoviral expression of FN14 enabled efficient induction of cell cycle re-entry in adult cardiomyocytes after TWEAK stimulation. CONCLUSION: Our data establish TWEAK as a positive regulator of cardiomyocyte proliferation.
No takes yet. Share an insight, caveat, or question.
Novoyatleva et al. (2009) studied Cardiomyocyte proliferation. TWEAK (TNF-related weak inducer of apoptosis) was evaluated on Cardiomyocyte proliferation (DNA synthesis, mitosis, cytokinesis, and cell numbers). Stimulation of neonatal rat cardiomyocytes with TWEAK increased DNA synthesis, mitosis, and cardiomyocyte numbers via FN14 signaling, establishing TWEAK as a positive regulator of proliferation.
Synapse has enriched 10 related papers. Consider them for comparative context: